Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD

Author： Thornton Snider Julia   Luna Yesenia   Wong Ken S.   Zhang Jie   Chen Susan S.   Gless Patrick J.   Goldman Dana P.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.28, Iss.12, 2012-12, pp. : 1959-1967

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhaled Corticosteroids in COPD: A Controversy

By  

Respiration, Vol. 80, Iss. 2, 2010-05 ,pp. : 89-95

Karger

Access to resources Recommend Favorite

Effects of Inhaled Corticosteroids with Different Lung Deposition on Exhaled Hydrogen Peroxide in Stable COPD Patients

By  

Respiration, Vol. 70, Iss. 3, 2003-08 ,pp. : 242-248

Karger

Access to resources Recommend Favorite

Chronic Eosinophilic Pneumonia: Treatment with Inhaled Corticosteroids

By  

Respiration, Vol. 70, Iss. 4, 2003-09 ,pp. : 362-366

Karger

Access to resources Recommend Favorite

Inhaled Corticosteroids as Additional Treatment in Alpha-1-Antitrypsin-Deficiency-Related COPD

By  

Respiration, Vol. 76, Iss. 1, 2008-03 ,pp. : 61-68

Karger

Access to resources Recommend Favorite

Current Perspectives on the Contribution of Inhaled Corticosteroids to an Increased Risk for Diabetes Onset and Progression in Patients with Chronic Obstructive Pulmonary Disease

By  

Respiration, Vol. 89, Iss. 1, 2014-11 ,pp. : 66-75

Karger

Access to resources Recommend Favorite